Whitepaper , Drug Substance , Formulation Development

Strategies for Accelerating the Development of Modified Release Oral Forms


Modified-Release (MR) drug delivery can also have commercial benefits and is prevalent as part of product life-cycle management (LCM). Modest reformulation of an already approved drug from an IR to MR format allows both line and patent extension opportunities and continued market exclusivity.